<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03118518</url>
  </required_header>
  <id_info>
    <org_study_id>MDT16012AFS001</org_study_id>
    <nct_id>NCT03118518</nct_id>
  </id_info>
  <brief_title>STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation</brief_title>
  <acronym>STOP AF First</acronym>
  <official_title>STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To provide data demonstrating the safety and effectiveness of the Arctic Front Advance™
      Cardiac CryoAblation Catheter for the treatment of recurrent symptomatic paroxysmal atrial
      fibrillation, without the requirement that the subjects be drug refractory.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with paroxysmal atrial fibrillation with no history of treatment with
      anti-arrhythmic drugs are randomized 1:1 to either an anti-arrhythmic drug or pulmonary vein
      isolation using the cryoballon catheter.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 16, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary efficacy endpoint - Treatment success at 12 months after antiarrhythmic drug (AAD) initiation or ablation utilizing the Arctic Front Advance™ Cardiac CryoAblation Catheter.</measure>
    <time_frame>Randomization to 12 months</time_frame>
    <description>Measured by success or failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary safety endpoint - Rate of composite list of serious adverse events.</measure>
    <time_frame>Randomization to 12 months</time_frame>
    <description>Measured by rate of composite list of serious adverse events.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Atrial Fibrillation New Onset</condition>
  <arm_group>
    <arm_group_label>Anti-arrhythmic drug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cryoablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryoablation</intervention_name>
    <description>Pulmonary vein isolation via ablation with cryoballon catheter</description>
    <arm_group_label>Cryoablation</arm_group_label>
    <other_name>ArcticFront Advance Cardiac CryoAblation Catheter</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antiarrhythmic drug</intervention_name>
    <description>Antiarrhythmic drug initiation</description>
    <arm_group_label>Anti-arrhythmic drug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A diagnosis of symptomatic paroxysmal AF with the following documentation: (1)
             physician's note indicating recurrent self- terminating AF or paroxysmal AF; and (2)
             any ECG documented AF within 6 months prior to enrollment.

          -  Age 18-80

        Exclusion Criteria:

          -  History of AF treatment with class I or III antiarrhythmic drug, including sotalol,
             with the intention to prevent an AF recurrence. However, patients pretreated with
             above AAD for less than 7 days with the intention to convert an AF episode are
             allowed.

          -  Prior persistent AF (cardioversion after 48 hours or continuous AF that is sustained
             &gt;7 days)

          -  Left atrial diameter greater than 5.0 cm

          -  Prior left atrial ablation or left atrial surgical procedure

          -  Presence or likely implant of a permanent pacemaker, biventricular pacemaker, loop
             recorder, or any type of implantable cardiac defibrillator (with or without
             biventricular pacing function)

          -  Body mass index (BMI) &gt;35 kg/m2

          -  Presence of any pulmonary vein stents

          -  Known presence of any pre-existing pulmonary vein stenosis

          -  Pre-existing hemidiaphragmatic paralysis

          -  Presence of any cardiac valve prosthesis

          -  Moderate or severe mitral valve regurgitation or stenosis

          -  Any cardiac surgery, myocardial infarction, percutaneous coronary intervention/
             percutaneous transluminal coronary angioplasty or coronary artery stenting which
             occurred during the 90 day interval preceding the date the subject signed the Informed
             Consent Form

          -  Unstable angina

          -  New York Heart Association (NYHA) class III or IV congestive heart failure and/or
             known left ventricular ejection fraction (LVEF) less than 45%

          -  Diagnosis of primary pulmonary hypertension

          -  Rheumatic heart disease

          -  Thrombocytosis, thrombocytopenia

          -  Contraindication to anticoagulation therapy

          -  Active systemic infection

          -  Hypertrophic cardiomyopathy

          -  Cryoglobulinemia

          -  Known reversible causes of AF, including but not limited to uncontrolled
             hyperthyroidism, obstructive sleep apnea, and acute alcohol toxicity.

          -  Any cerebral ischemic event (strokes or transient ischemic attacks) which occurred
             during the 180 day interval preceding the date the subject signed the Informed Consent
             Form, or any known unresolved complications from previous stroke/transient ischemic
             attack

          -  Existing thrombus

          -  Pregnancy

          -  Patient with life expectancy that makes it unlikely 12 months of follow-up will be
             completed.

          -  Current or anticipated participation in any other clinical trial of a drug, device or
             biologic during the duration of this study not pre-approved by Medtronic

          -  Patients with contraindications to a Holter monitor

          -  Unwilling or unable to comply fully with study procedures and follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oussama Wazni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gopi Dandamudi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University Krannert Institute of Cardiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steve Nissen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grandview Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alaska Heart Institute</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>50266-8209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hoag Hospital Newport Beach</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010-3017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tallahassee Research Institute Inc</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308-4646</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BayCare Medical Group Cardiology</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellstar Research Institute</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krannert Institute of Cardiology</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266-8209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Our Lady of the Lake Office of Research</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>50266-8209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southcoast Health System</name>
      <address>
        <city>New Bedford</city>
        <state>Massachusetts</state>
        <zip>02740</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System - University Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>50266-8209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthEast Saint Josephs Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102-1062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bryan Heart</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>07450-2726</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450-2726</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Integris Baptist Medical Center, Inc.</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112-4418</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Saint Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Health</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17821</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Cardiovascular Services</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>50266-8209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Arrhythmia Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

